Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

The use of 4DCT to reduce lung dose: a dosimetric analysis.

Khan F, Bell G, Antony J, Palmer M, Balter P, Bucci K, Chapman MJ.

Med Dosim. 2009 Winter;34(4):273-8. doi: 10.1016/j.meddos.2008.11.005. Epub 2009 Jan 1.

PMID:
19854385
2.

A novel four-dimensional radiotherapy planning strategy from a tumor-tracking beam's eye view.

Li G, Cohen P, Xie H, Low D, Li D, Rimner A.

Phys Med Biol. 2012 Nov 21;57(22):7579-98. doi: 10.1088/0031-9155/57/22/7579. Epub 2012 Oct 26.

PMID:
23103415
3.

Investigation of simple IMRT delivery techniques for non-small cell lung cancer patients with respiratory motion using 4DCT.

Reitz B, Parda DS, Colonias A, Lee V, Miften M.

Med Dosim. 2009 Summer;34(2):158-69. doi: 10.1016/j.meddos.2008.07.001. Epub 2008 Aug 12.

PMID:
19410146
4.

Evaluation and comparison of New 4DCT based strategies for proton treatment planning for lung tumors.

Wang N, Patyal B, Ghebremedhin A, Bush D.

Radiat Oncol. 2013 Mar 25;8:73. doi: 10.1186/1748-717X-8-73.

5.

Investigating the potential impact of four-dimensional computed tomography (4DCT) on toxicity, outcomes and dose escalation for radical lung cancer radiotherapy.

Cole AJ, O'Hare JM, McMahon SJ, McGarry CK, Butterworth KT, McAleese J, Jain S, Hounsell AR, Prise KM, Hanna GG, O'Sullivan JM.

Clin Oncol (R Coll Radiol). 2014 Mar;26(3):142-50. doi: 10.1016/j.clon.2013.11.024. Epub 2013 Dec 9.

PMID:
24332210
6.

Dosimetric study of a respiratory gating technique based on four-dimensional computed tomography in non-small-cell lung cancer.

Lin H, Lu H, Shu L, Huang H, Chen H, Chen J, Cheng J, Pang Q, Peng L, Gu J, Lu Z.

J Radiat Res. 2014 May;55(3):583-8. doi: 10.1093/jrr/rrt145. Epub 2014 Jan 21.

7.

Evaluation of dosimetric variance in whole breast forward-planned intensity-modulated radiotherapy based on 4DCT and 3DCT.

Wang W, Bin Li J, Hu HG, Sun T, Xu M, Fan TY, Shao Q.

J Radiat Res. 2013 Jul 1;54(4):755-61. doi: 10.1093/jrr/rrs143. Epub 2013 Jan 24.

8.

Consequences of anatomic changes and respiratory motion on radiation dose distributions in conformal radiotherapy for locally advanced non-small-cell lung cancer.

Britton KR, Starkschall G, Liu H, Chang JY, Bilton S, Ezhil M, John-Baptiste S, Kantor M, Cox JD, Komaki R, Mohan R.

Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):94-102. doi: 10.1016/j.ijrobp.2008.04.016. Epub 2008 Oct 17.

PMID:
18929448
9.
10.

Dosimetric impact of breathing motion in lung stereotactic body radiotherapy treatment using intensity modulated radiotherapy and volumetric modulated arc therapy [corrected].

Rao M, Wu J, Cao D, Wong T, Mehta V, Shepard D, Ye J.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):e251-6. doi: 10.1016/j.ijrobp.2011.12.001. Epub 2012 Feb 24. Erratum in: Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):462. Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):859.

PMID:
22365622
11.

Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.

Wang L, Hayes S, Paskalev K, Jin L, Buyyounouski MK, Ma CC, Feigenberg S.

Radiother Oncol. 2009 Jun;91(3):314-24. doi: 10.1016/j.radonc.2008.11.018. Epub 2008 Dec 26.

PMID:
19111362
12.

Dosimetric benefits of respiratory gating: a preliminary study.

Butler LE, Forster KM, Stevens CW, Bloch C, Liu HH, Tucker SL, Komaki R, Liao Z, Starkschall G.

J Appl Clin Med Phys. 2004 Winter;5(1):16-24. Epub 2004 Jan 1.

PMID:
15753930
13.

Incorporating heterogeneity correction and 4DCT in lung stereotactic body radiation therapy (SBRT): The effect on target coverage, organ-at-risk doses, and dose conformity.

Franks KN, Purdie TG, Dawson LA, Bezjak A, Jaffray DA, Bissonnette JP.

Med Dosim. 2010 Summer;35(2):101-7. doi: 10.1016/j.meddos.2009.03.007. Epub 2009 Apr 24.

PMID:
19931021
14.

A treatment planning study of the potential of geometrical tracking for intensity modulated proton therapy of lung cancer.

Munck af Rosenschöld P, Aznar MC, Nygaard DE, Persson GF, Korreman SS, Engelholm SA, Nyström H.

Acta Oncol. 2010 Oct;49(7):1141-8. doi: 10.3109/0284186X.2010.500620.

PMID:
20831506
15.

Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy.

Liao ZX, Komaki RR, Thames HD Jr, Liu HH, Tucker SL, Mohan R, Martel MK, Wei X, Yang K, Kim ES, Blumenschein G, Hong WK, Cox JD.

Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):775-81. doi: 10.1016/j.ijrobp.2009.02.032. Epub 2009 Jun 8.

PMID:
19515503
16.
17.

Multiple anatomy optimization of accumulated dose.

Watkins WT, Moore JA, Gordon J, Hugo GD, Siebers JV.

Med Phys. 2014 Nov;41(11):111705. doi: 10.1118/1.4896104.

18.

A study on the dosimetric accuracy of treatment planning for stereotactic body radiation therapy of lung cancer using average and maximum intensity projection images.

Huang L, Park K, Boike T, Lee P, Papiez L, Solberg T, Ding C, Timmerman RD.

Radiother Oncol. 2010 Jul;96(1):48-54. doi: 10.1016/j.radonc.2010.04.003. Epub 2010 Apr 27.

PMID:
20430460
19.

Comparison of the planning target volume based on three-dimensional CT and four-dimensional CT images of non-small-cell lung cancer.

Li FX, Li JB, Zhang YJ, Liu TH, Tian SY, Xu M, Shang DP, Ma CS.

Radiother Oncol. 2011 May;99(2):176-80. doi: 10.1016/j.radonc.2011.03.015. Epub 2011 May 4.

PMID:
21549440
20.

Individualized margins in 3D conformal radiotherapy planning for lung cancer: analysis of physiological movements and their dosimetric impacts.

Germain F, Beaulieu L, Fortin A.

Med Dosim. 2008 Spring;33(1):48-54. doi: 10.1016/j.meddos.2007.05.003.

PMID:
18262123

Supplemental Content

Support Center